Annual CFI
-$5.90B$4.12B-232.20%
Summary
- Current Value
- As of today, GSK annual cash from investing is -$5.90B, down -232.20% on
- Historical Performance
- GSK annual cash from investing is up +45.81% over the past 3 years, down -319.58% over the past 5 years
- All-Time High Comparison
- GSK annual cash from investing is currently -165.05% below its historical high of $9.06B set on
- 3-Year Low Comparison
- GSK annual cash from investing is +45.81% above its 3-year low of -$10.88B reached on an earlier date
- Sector Comparison
- GSK annual cash from investing is higher than 0.69% of companies in Healthcare sector
Cash From Investing Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Investing | -$5.90B | -232.2% | +45.8% | -319.6% | -91.7% | |
| Quarterly Cash From Investing | -$1.78B | -12.9% | -160.8% | -2540.3% | -237.5% | |
| TTM Cash From Investing | -$7.94B | -154.8% | -19.3% | -391.3% | -538.3% | |
| Price | $49.81 | +36.0% | +37.3% | +27.9% | +13.3% | |
| Annual Cash From Operations | $9.62B | +23.7% | +17.9% | -1.9% | +1.4% | |
| Annual Cash From Financing | -$3.96B | +24.4% | -293.4% | +66.7% | +46.5% | |
| Annual CAPEX | $3.93B | +3.2% | +41.4% | +37.0% | +55.9% | |
| Annual Free Cash Flow | $5.69B | +43.2% | +5.8% | -17.9% | -18.3% | |
| Annual Total Assets | $82.21B | +10.4% | +13.6% | -25.2% | +24.3% |
Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$1.77B | -232.2% | |
| 5Y | $2.69B | N/A | -319.6% |
| All | $9.06B | -165.1% |
Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$10.88B | N/A | +45.8% |
| 5Y | -$10.88B | +45.8% | |
| All | -$14.62B | +59.7% |
Cash From Investing History
FAQ
What is the current annual cash from investing of GSK?
As of today, GSK annual cash from investing is -$5.90B
What is 1-year change in GSK annual cash from investing?
GSK annual cash from investing is down -232.20% year-over-year
What is 3-year change in GSK annual cash from investing?
GSK annual cash from investing is up +45.81% over the past 3 years
How far is GSK annual cash from investing from its all-time high?
GSK annual cash from investing is currently -165.05% below its historical high of $9.06B set on December 31, 2015
How does GSK annual cash from investing rank versus sector peers?
GSK annual cash from investing is higher than 0.69% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Quarterly CFI
-$1.78B$1.40B+43.96%
Summary
- Current Value
- As of today, GSK quarterly cash from investing is -$1.78B, up +43.96% on
- Historical Performance
- GSK quarterly cash from investing is down -12.88% year-over-year, down -160.78% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash from investing is currently -116.73% below its historical high of $10.66B set on
- 3-Year Low Comparison
- GSK quarterly cash from investing is +43.96% above its 3-year low of -$3.18B reached on
- Sector Comparison
- GSK quarterly cash from investing is higher than 1.22% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Investing | -$1.78B | +44.0% | -12.9% | -160.8% | -2540.3% | |
| Annual Cash From Investing | -$5.90B | – | -232.2% | +45.8% | -319.6% | |
| TTM Cash From Investing | -$7.94B | -2.6% | -154.8% | -19.3% | -391.3% | |
| Price | $49.81 | -14.8% | +36.0% | +37.3% | +27.9% | |
| Quarterly Cash From Operations | $1.48B | -45.9% | +4.3% | +1185.2% | +340.9% | |
| Quarterly Cash From Financing | $229.06M | -79.0% | -81.5% | +192.0% | +112.9% | |
| Quarterly CAPEX | $596.89M | -55.7% | +5.8% | -7.1% | +22.3% | |
| Quarterly Free Cash Flow | $886.58M | -36.5% | +3.4% | +268.1% | +684.5% | |
| Quarterly Total Assets | $82.91B | +0.8% | +5.8% | +14.4% | -23.0% |
Quarterly Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$823.69M | -116.6% | |
| 3Y | $924.65M | -292.9% | |
| 5Y | $924.65M | -292.9% | |
| All | $10.66B | -116.7% |
Quarterly Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.18B | +44.0% | |
| 3Y | -$3.18B | +44.0% | |
| 5Y | -$5.00B | +64.3% | |
| All | -$13.29B | +86.6% |
Quarterly Cash From Investing History
FAQ
What is the current quarterly cash from investing of GSK?
As of today, GSK quarterly cash from investing is -$1.78B
What is GSK quarterly cash from investing most recent change?
GSK quarterly cash from investing was up +43.96% on March 31, 2026
What is 1-year change in GSK quarterly cash from investing?
GSK quarterly cash from investing is down -12.88% year-over-year
How far is GSK quarterly cash from investing from its all-time high?
GSK quarterly cash from investing is currently -116.73% below its historical high of $10.66B set on March 31, 2015
How does GSK quarterly cash from investing rank versus sector peers?
GSK quarterly cash from investing is higher than 1.22% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM CFI
-$7.94B$203.50M-2.63%
Summary
- Current Value
- As of today, GSK TTM cash from investing is -$7.94B, down -2.63% on
- Historical Performance
- GSK TTM cash from investing is down -154.78% year-over-year, down -19.33% over the past 3 years
- All-Time High Comparison
- GSK TTM cash from investing is currently -185.14% below its historical high of $9.33B set on
- 3-Year Low Comparison
- GSK TTM cash from investing is at its 3-year low
- Sector Comparison
- GSK TTM cash from investing is higher than 0.84% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Investing | -$7.94B | -2.6% | -154.8% | -19.3% | -391.3% | |
| Annual Cash From Investing | -$5.90B | – | -232.2% | +45.8% | -319.6% | |
| Quarterly Cash From Investing | -$1.78B | +44.0% | -12.9% | -160.8% | -2540.3% | |
| Price | $49.81 | -14.8% | +36.0% | +37.3% | +27.9% | |
| TTM Cash From Operations | $9.72B | +0.6% | +20.2% | +98.6% | +8.2% | |
| TTM Cash From Financing | -$3.17B | -46.9% | -13.1% | +64.9% | +74.5% | |
| TTM CAPEX | $3.98B | +0.8% | +7.7% | +51.0% | +36.5% | |
| TTM Free Cash Flow | $5.74B | +0.5% | +30.7% | +154.0% | -5.4% | |
| Quarterly Total Assets | $82.91B | +0.8% | +5.8% | +14.4% | -23.0% |
TTM Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$3.12B | N/A | -154.8% |
| 3Y | $292.30M | -2817.6% | |
| 5Y | $2.73B | N/A | -391.3% |
| All | $9.33B | -185.1% |
TTM Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$7.94B | at low | |
| 3Y | -$7.94B | at low | |
| 5Y | -$10.88B | +27.0% | |
| All | -$19.30B | +58.8% |
TTM Cash From Investing History
FAQ
What is the current TTM cash from investing of GSK?
As of today, GSK TTM cash from investing is -$7.94B
What is GSK TTM cash from investing most recent change?
GSK TTM cash from investing was down -2.63% on March 31, 2026
What is 1-year change in GSK TTM cash from investing?
GSK TTM cash from investing is down -154.78% year-over-year
How far is GSK TTM cash from investing from its all-time high?
GSK TTM cash from investing is currently -185.14% below its historical high of $9.33B set on March 31, 2015
How does GSK TTM cash from investing rank versus sector peers?
GSK TTM cash from investing is higher than 0.84% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk